<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01613612</url>
  </required_header>
  <id_info>
    <org_study_id>GGH_201112_Ortho_1</org_study_id>
    <nct_id>NCT01613612</nct_id>
  </id_info>
  <brief_title>Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)</brief_title>
  <official_title>Control Study of Implantation of Enriched Bone Marrow Cells for the Treatment of Avascular Necrosis of Femoral Head</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of autologous enriched bone marrow cell
      implantation combined with core decompression to single core decompression for the treatment
      of avascular necrosis of femoral head.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of Visual Analogue Scale</measure>
    <time_frame>before invention and 24 months after invention</time_frame>
    <description>Change from baseline in 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of lequensne algofunctional index</measure>
    <time_frame>before invention and 24 months after invention</time_frame>
    <description>change from baseline in 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of WOMAC index</measure>
    <time_frame>before invention and 24 months after invention</time_frame>
    <description>change from baseline in 24 months</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Avascular Necrosis of Femur Head</condition>
  <arm_group>
    <arm_group_label>control group:core decompression</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>single core decompression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment group: BMCs+core decompression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enriched bone marrow cells combined with core decompression</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>core decompression</intervention_name>
    <description>minimal surgical invention to drill a core to the femoral head to release pressure</description>
    <arm_group_label>control group:core decompression</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enriched BMCs implantation combined with core decompression</intervention_name>
    <description>Patients are subjected to bone marrow aspiration from the anterior iliac crest. Mononuclear cells are enriched from patients' bone marrow by centrifuge, which are grafted with autologous cortical bone and implanted to the necrotic zone of the femoral head.</description>
    <arm_group_label>Treatment group: BMCs+core decompression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  femoral head necrosis patients

          -  stage I/II/III (Ficat)

          -  age from 18 to 55 years

          -  stop steroid treatment for minimal 6 months

        Exclusion Criteria:

          -  age younger than 18 or older than 55

          -  any hemopathy

          -  tumor

          -  femoral head/neck fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>June 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2012</study_first_posted>
  <last_update_submitted>August 12, 2012</last_update_submitted>
  <last_update_submitted_qc>August 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong General Hospital</investigator_affiliation>
    <investigator_full_name>Qiujiang Zheng</investigator_full_name>
    <investigator_title>Director of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

